Search research articles
Contact Us
Filters
Showing results (101-110 of 401) with videos related to
Page
of 41
Sort By:
JAMA Oncology
|
September 8, 2018
Information Transparency in the Drug Approval Process
Brian I Rini, Harold J Burstein, Daniel J George
Current Urology Reports
|
January 1, 2009
Integration of surgery and systemic therapy in the management of metastatic renal cancer
Anil A Thomas, Brian I Rini, Steven C Campbell
Current Opinion in Oncology
|
April 9, 2005
Renal cell carcinoma
W Kimryn Rathmell, Paul A Godley, Brian I Rini
Expert Review of Anticancer Therapy
|
December 13, 2005
Molecularly targeted therapy in renal cell carcinoma
W Kimryn Rathmell, Tricia M Wright, Brian I Rini
Expert Review of Anticancer Therapy
|
December 9, 2016
On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?
Frede Donskov, Daniel Y C Heng, Brian I Rini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 18, 2020
Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting
David H Aggen, Charles G Drake, Brian I Rini
Clinical Pharmacokinetics
|
May 8, 2016
Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor
Reza Khosravan, Robert J Motzer, Elena Fumagalli, et al.
Clinical Prostate Cancer
|
July 5, 2005
Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancer
Garth Beinart, Brian I Rini, Vivian Weinberg, et al.
Case Reports in Oncological Medicine
|
November 10, 2015
Is It Safe to Restart Antivascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma after Cardiac Ischemia?
Bo Zhao, Laura S Wood, Karen James, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2002
Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of prostate cancer
Brian I Rini, Vivian Weinberg, Robert Bok, et al.
Page
of 41
Search research articles
Search
Showing results (101-110 of 401) with videos related to
Sort By:
Page
of 41
JAMA Oncology
|
September 8, 2018
Information Transparency in the Drug Approval Process
Brian I Rini, Harold J Burstein, Daniel J George
Current Urology Reports
|
January 1, 2009
Integration of surgery and systemic therapy in the management of metastatic renal cancer
Anil A Thomas, Brian I Rini, Steven C Campbell
Current Opinion in Oncology
|
April 9, 2005
Renal cell carcinoma
W Kimryn Rathmell, Paul A Godley, Brian I Rini
Expert Review of Anticancer Therapy
|
December 13, 2005
Molecularly targeted therapy in renal cell carcinoma
W Kimryn Rathmell, Tricia M Wright, Brian I Rini
Expert Review of Anticancer Therapy
|
December 9, 2016
On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?
Frede Donskov, Daniel Y C Heng, Brian I Rini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 18, 2020
Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting
David H Aggen, Charles G Drake, Brian I Rini
Clinical Pharmacokinetics
|
May 8, 2016
Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor
Reza Khosravan, Robert J Motzer, Elena Fumagalli, et al.
Clinical Prostate Cancer
|
July 5, 2005
Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancer
Garth Beinart, Brian I Rini, Vivian Weinberg, et al.
Case Reports in Oncological Medicine
|
November 10, 2015
Is It Safe to Restart Antivascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma after Cardiac Ischemia?
Bo Zhao, Laura S Wood, Karen James, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2002
Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of prostate cancer
Brian I Rini, Vivian Weinberg, Robert Bok, et al.
Page
of 41